CDC Recommends Updated Pfizer, Moderna COVID-19 Vaccine

RTTNews | 279 days ago
CDC Recommends Updated Pfizer, Moderna COVID-19 Vaccine

(RTTNews) - The Centers for Disease Control and Prevention or CDC has recommended everyone 6 months and older to get an updated COVID-19 vaccine ahead of the virus season this fall and winter.

The agency expects the updated COVID-19 vaccines from Pfizer-BioNTech and Moderna, which was approved by the U.S. Food and Drug Administration earlier this week, to be available later this week.

Updated COVID-19 vaccine is recommended for those who have not received a COVID-19 vaccine in the past 2 months.

It was on Monday that the FDA approved and authorized for emergency use updated COVID-19 vaccines against currently circulating variants and to provide better protection against serious consequences of COVID-19, including hospitalization and death.

The FDA approval was given to the updated mRNA vaccines for 2023-2024 manufactured by ModernaTX and Pfizer. These vaccines have been updated to include a monovalent (single) component that corresponds to the Omicron variant XBB.1.5.

According to CDC, vaccination remains the best protection against COVID-19-related hospitalization and death, and also reduces effects of Long COVID, which can develop during or following acute infection and last for an extended duration Meanwhile, due to the changing nature of virus that causes COVID-19, protection from COVID-19 vaccines declines over time. An updated COVID-19 vaccine can restore protection and provide enhanced protection against variants.

The agency noted that greater protection against illness and hospitalization was reported during last season in those who received a 2022-2023 COVID-19 vaccine than those who did not receive a 2022-2023 vaccine.

As per the FDA, individuals 5 years of age and older regardless of previous vaccination are eligible to receive a single dose of an updated mRNA COVID-19 vaccine at least 2 months since the last dose of any COVID-19 vaccine.

Individuals 6 months through 4 years of age who have previously been vaccinated are eligible to receive one or two doses of an updated mRNA vaccine.

Further, unvaccinated individuals 6 months through 4 years of age are eligible to receive three doses of the updated authorized Pfizer-BioNTech vaccine or two doses of the updated authorized Moderna vaccine.

COVID-19 vaccine is still offered in the country free of cost. For people with health insurance, most plans will cover the vaccine at no cost. Meanwhile, those lacking health insurance or with health plans that do not cover the cost can get a free vaccine from their local health centers; state, local, tribal, or territorial health department; and pharmacies participating in the CDC's Bridge Access Program.

In this fall and winter virus season, vaccines are available for the three viruses responsible for most hospitalizations - COVID-19, RSV, and flu, CDC said.

For More Such Health News, visit rttnews.com

read more
Pfizer's Hospira Recalls Select Hydrochloride Injection Carpuject Units

Pfizer's Hospira Recalls Select Hydrochloride Injection Carpuject Units

Hospira, Inc., affiliated to dug major Pfizer Inc., is recalling select lots of Buprenorphine Hydrochloride Injection Carpuject Units and Labetalol Hydrochloride Injection Carpuject Units, according to the U.S. Food and Drug Administration. The recall was initiated due to the potential for incomplete crimp seals. The company has received one customer complaint for one leaking unit.
RTTNews | 26 days ago
Amazon, Microsoft, Pfizer To Invest Billions In French Projects

Amazon, Microsoft, Pfizer To Invest Billions In French Projects

Major companies, including Amazon.com Inc., Microsoft Corp., Morgan Stanley, Pfizer and others, have announced around 15 billion euros or $16.2 billion worth foreign investments in France as part of the country's annual 'Choose France' business summit, reports said. French President Emmanuel Macron kicks off the summit of 180 CEOs and executives on Monday, aiming to showcase foreign investment.
RTTNews | 36 days ago
Pfizer Boost FY24 Adj. EPS Outlook - Update

Pfizer Boost FY24 Adj. EPS Outlook - Update

While reporting financial results for the first quarter, drug major Pfizer Inc. (PFE) raised its adjusted earnings guidance for the full-year 2024, while maintaining annual revenue outlook.
RTTNews | 48 days ago
Moderna Stock Up 6% As Q4 Results Top Estimates

Moderna Stock Up 6% As Q4 Results Top Estimates

Biotechnology company Moderna reported a profit for the fourth quarter that plunged from last year, reflecting a sharp drop in COVID-19 vaccines sales. However, both earnings per share and revenues for the quarter topped analysts' expectations. The company also reaffirmed its 2024 product sales outlook.
RTTNews | 117 days ago
Pfizer Closes $43 Bln All-cash Acquisition Of Seagen

Pfizer Closes $43 Bln All-cash Acquisition Of Seagen

Pfizer Inc. (PFE) announced Thursday the successful completion of its acquisition of biotechnology company Seagen Inc. (SGEN). Pfizer completed its acquisition of all outstanding common stock of Seagen for $229 in cash per share, for a total enterprise value of approximately $43 billion.
RTTNews | 187 days ago
Pfizer Reaffirms FY23 Outlook - Update

Pfizer Reaffirms FY23 Outlook - Update

While reporting financial results for the third quarter, drug major Pfizer Inc. (PFE) reaffirmed its adjusted earnings and revenue guidance for the full-year 2023.
RTTNews | 231 days ago